Clinical Trial Update: Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring umbilical cord-derived mesenchymal stem cells for viral pneumonia due to a novel coronavirus; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia
• Viral Pneumonia

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: ZhiYong Peng | Conditions: Pneumonia, Viral, Pneumonia, Ventilator-Associated | Phase 2 | Status: UNKNOWN